Muscle disorders of equine athletes

Equine Sports Medicine and Surgery

Volumn , Issue , 2004, Pages 77-110

  Piercy, Richard J ^a   Rivero, José Luis L ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942918908     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2671-3.50010-6     Document Type: Chapter

References (231)

1. Belcastro AN, Shewchuk LD, Raj DA Exercise-induced muscle injury: a calpain hypothesis. Mol Cell Biochem 1998, 179:135-145.
2. Gissel H, Clausen T Excitation-induced Ca 2+ influx and skeletal muscle cell damage. Acta Physiol Scand 2001, 171:327-334.
3. Sandri M, Carraro U Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 1999, 31:1373-1390.
4. Tidball JG Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 1995, 27:1022-1032.
5. Hurme T, Kalimo H, Lehto M, Jarvinen M Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med Sci Sports Exerc 1991, 23:801-810.
6. Grounds MD Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol 1999, 12:535-543.
7. Zammit P, Beauchamp J The skeletal muscle satellite cell: stem cell or son of stem cell?. Differentiation 2001, 68:193-204.
8. Rantanen J, Hurme T, Lukka R, Heino J, Kalimo H Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest 1995, 72:341-347.
9. Kaariainen M, Jarvinen T, Jarvinen M, Rantanen J, Kalimo H Relation between myofibers and connective tissue during muscle injury repair. Scand J Med Sci Sports 2000, 10:332-337.
10. Dubowitz V, Sewry C, Fitzsimons R Muscle biospy: a practical approach 1985, Baillière Tindall, London.
11. Rivero JL, Letelier AI. Skeletal muscle profile of show jumpers: physiological and pathological considerations. Conference on Equine Sports Medicine and Science, Dortmund, 2000. Gestalt manufaktur GmbH.
12. Harris P, Mayhew I Musculoskeletal disease. Equine internal medicine 1998, 384-385. Saunders, Philadelphia. S. Reed, W. Bayley (Eds.).
13. Sprinkle F, Swerczek T, Ward Crowe M Gastrocnemius muscle rupture and hemorrhage in foals. Equine Pract 1985, 7:10-17.
14. Schneider J, Guffy M, Leipold H Ruptured flexor muscles in a neonatal foal. Equine Pract 1986, 8:11-15.
15. Stashak T Serratus ventralis rupture. Adams' lameness in horses 1987, 693-694. Lea and Febiger, Philadelphia. T. Stashak (Ed.).
16. Morris E, Seeherman HJ, O'Callaghan MW, Schelling SH, Paradis MR, Steckel RS Scintigraphic identification of skeletal muscle damage in horses 24 hours after strenuous exercise. Equine Vet J 1991, 23:347-352.
17. Eddy AL, van Hoogmoed LM, Snyder JR The role of thermography in the management of equine lameness. Vet J 2001, 162:172-181.
18. Reef VB Equine diagnostic ultrasound 1998, 143-149. Saunders, Philadelphia.
19. Bramlage LR, Reed SM, Embertson RM Semitendinosus tenotomy for treatment of fibrotic myopathy in the horse. J Am Vet Med Assoc 1985, 186:565-567.
20. Gibson JS, Ellory JC More theories than facts: equine rhabdomyolysis. Equine Vet J 1993, 25:327-328.
21. Warren JD, Blumbergs PC, Thompson PD Rhabdomyolysis: a review. Muscle Nerve 2002, 25:332-347.
22. Hodgson DR Diseases of muscle. Equine medicine and surgery 1999, 1489-1490. Mosby, St Louis, Missouri. P. Colahan (Ed.).
23. McEwen SA, Hulland TJ Histochemical and morphometric evaluation of skeletal muscle from horses with exertional rhabdomyolysis (tying-up). Vet Pathol 1986, 23:400-410.
24. Snow DH, Valberg SJ Muscle anatomy, physiology, and adaptions to exercise and training. The athletic horse: principles and practice of equine sports medicine 1994, 169. Saunders, Philadelphia. D.R. Hodgson, R.J. Rose (Eds.).
25. Toutain PL, Lassourd V, Costes G, et al. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J Vet Pharmacol Ther 1995, 18:226-235.
26. Koterba A, Carlson GP Acid-base and electrolyte alterations in horses with exertional rhabdomyolysis. J Am Vet Med Assoc 1982, 180:303-306.
27. Schott HC, Hodgson DR, Bayly WM Haematuria, pigmenturia and proteinuria in exercising horses. Equine Vet J 1995, 27:67-72.
28. Kohn CW, Chew DJ Laboratory diagnosis and characterization of renal disease in horses. Vet Clin North Am Equine Pract 1987, 3:585-615.
29. Valberg SJ Spinal muscle pathology. Vet Clin North Am Equine Pract 1999, 15:87-96. vi-vii.
30. Andrews FM Acute rhabdomyolysis. Vet Clin North Am Equine Pract 1994, 10:567-573.
31. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 1998, 273:31731-31737.
32. Fruen BR, Mickelson JR, Louis CF Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem 1997, 272:26965-26971.
33. Lopez JR, Linares N, Cordovez G, Terzic A Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflugers Arch 1995, 430:293-295.
34. Court MH, Engelking LR, Dodman NH, Anwer MS, Seeler DC, Clark M Pharmacokinetics of dantrolene sodium in horses. J Vet Pharmacol Ther 1987, 10:218-226.
35. Beech J Chronic exertional rhabdomyolysis. Vet Clin North Am Equine Pract 1997, 13:145-168.
36. Valverde A, Boyd CJ, Dyson DH, Pascoe PJ Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. J Am Vet Med Assoc 1990, 197:1051-1053.
37. Martin BB, Reef VB, Parente EJ, Sage AD Causes of poor performance of horses during training, racing, or showing: 348 cases (1992-1996). J Am Vet Med Assoc 2000, 216:554-558.
38. MacLeay JM, Valberg SJ, Pagan JD, Xue JL, de la Corte FD, Roberts J Effect of ration and exercise on plasma creatine kinase activity and lactate concentration in Thoroughbred horses with recurrent exertional rhabdomyolysis. Am J Vet Res 2000, 61:1390-1395.
39. Valberg S, Jonsson L, Lindholm A, Holmgren N Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J 1993, 25:11-16.
40. McKenzie EC, Valberg SJ, Godden SM, et al. Plasma and urine electrolyte and mineral concentrations in Thoroughbred horses with recurrent exertional rhabdomyolysis after consumption of diets varying in cation-anion balance. Am J Vet Res 2002, 63:1053-1060.
41. Toribio RE, Kohn CW, Chew DJ, Sams RA, Rosol TJ Comparison of serum parathyroid hormone and ionized calcium and magnesium concentrations and fractional urinary clearance of calcium and phosphorus in healthy horses and horses with enterocolitis. Am J Vet Res 2001, 62:938-947.
42. Clarke LL, Argenzio RA, Roberts MC Effect of meal feeding on plasma volume and urinary electrolyte clearance in ponies. Am J Vet Res 1990, 51:571-576.
43. Kohn CW, Strasser SL 24-hour renal clearance and excretion of endogenous substances in the mare. Am J Vet Res 1986, 47:1332-1337.
44. Morris DD, Divers TJ, Whitlock RH Renal clearance and fractional excretion of electrolytes over a 24-hour period in horses. Am J Vet Res 1984, 45:2431-2435.
45. Harris P, Colles C The use of creatinine clearance ratios in the prevention of equine rhabdomyolysis: a report of four cases. Equine Vet J 1988, 20:459-463.
46. McKenzie DC, Valberg SJ, Godden S, et al. Volumetric urine collection versus single sample collection in horses consuming diets varying in dietary cation-anion balance 2002, 20th Annual ACVIM Forum, Dallas, TX.
47. Valentine B, Divers TJ, Murphy DJ, Todhunter P Muscle biopsy diagnosis of equine motor neuron disease and equine polysaccharide storage myopathy. Equine Vet Educ 1998, 10:42-50.
48. Lindholm A, Johansson HE, Kjaersgaard P Acute rhabdomyolysis ('tying-up') in standardbred horses. A morphological and biochemical study. Acta Vet Scand 1974, 15:325-339.
49. Meijer AE, van den Hoven R, Wensing T, Breukink HJ [Histochemical changes in skeletal muscles of racehorses susceptible to rhabdomyolysis after exertion. II. Later myopathological and regeneration phenomena]. Acta Histochem 1989, 87:13-21.
50. Meijer AE, van den Hoven R, Wensing T, Breukink HJ [Histochemical changes in skeletal muscles of racehorses susceptible to rhabdomyolysis after exertion. I. Early myopathological changes]. Acta Histochem 1989, 87:1-11.
51. Andrews FM, Reed SM, Johnson GC Muscle biopsy in the horse: its indications, techniques and complications. Vet Med US Equine Pract 1993, 357-365.
52. Valberg SJ, Cardinet GH, Carlson GP, DiMauro S Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 1992, 2:351-359.
53. Rivero JL, Glitz F. Equine polysaccharide storage myopathy: differential diagnosis with unspecific exertional rhabdomyolysis. Conference on Equine Sports Medicine and Science, Dortmund, 2000. Gestalt manufaktur.
54. Quiroz-Rothe E, Novales M, Aguilera-Tejero E, Rivero JL Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain. Equine Vet J 2002, 34:171-176.
55. Valentine BA, Credille KM, Lavoie JP, et al. Severe polysaccharide storage myopathy in Belgian and Percheron draught horses. Equine Vet J 1997, 29:220-225.
56. Valentine BA, McDonough SP, Chang YF, Vonderchek AJ Polysaccharide storage myopathy in Morgan, Arabian, and Standardbred related horses and Welsh-cross ponies. Vet Pathol 2000, 37:193-196.
57. Valentine BA, Habecker PL, Patterson JS, et al. Incidence of polysaccharide storage myopathy in draft horse-related breeds: a necropsy study of 37 horses and a mule. J Vet Diagn Invest 2001, 13:63-68.
58. Gerber V, Glitz F, Welle M Discussion of four cases of polysaccharide storage myopathy (PSSM). Pferdehelkubde 2001, 17:11-20.
59. DiMauro S, Lamperti C Muscle glycogenoses. Muscle Nerve 2001, 24:984-999.
60. de la Corte FD, Valberg SJ, MacLeay JM, Mickelson JR Developmental onset of polysaccharide storage myopathy in 4 quarter horse foals. J Vet Intern Med 2002, 16:581-587.
61. de la Corte FD, Valberg SJ, MacLeay JM, Williamson SE, Mickelson JR Glucose uptake in horses with polysaccharide storage myopathy. Am J Vet Res 1999, 60:458-462.
62. de la Corte FD, Valberg SJ, Mickelson JR, Hower-Moritz M Blood glucose clearance after feeding and exercise in polysaccharide storage myopathy. Equine Vet J 1999, 30:324-328. (suppl).
63. Lentz L, Valberg S, Herold L, Onan G, Mickelson J, Gallant E Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am J Vet Res 2002, 63(12):1724-1731.
64. Valberg SJ, Mickelson JR, Gallant EM, MacLeay JM, Lentz L, de la Corte F Exertional rhabdomyolysis in quarter horses and thoroughbreds: one syndrome, multiple aetiologies. Equine Vet J 1999, 30:533-538. (suppl).
65. Poels PJ, Gabreels FJ Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993, 95:175-192.
66. MacLeay JM, Sorum SA, Valberg SJ, Marsh WE, Sorum MD Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 1999, 60:1562-1566.
67. McKenzie EC, Valberg SJ, Godden SM, et al. Effect of dietary starch, fat and bicarbonate content on exercise responses and serum creatine kinase activity in equine recurrent exertional rhabdomyolysis. J Vet Intern Med 2003, 17:693-701.
68. Firshman A, Valberg SJ, Finno C, Bender JB Epidemiological aspects of polysaccharide storage myopathy (PSSM) in Quarter Horses (QH) 2002, 20th Annual ACVIM Forum, Dallas, TX.
69. Valentine B, Reynolds A, Ducharme N, et al. Dietary therapy of equine polysaccharide storage myopathy. Equine Pract 1997, 19:30-37.
70. Holland JL, Kronfeld DS, Meacham TN Behavior of horses is affected by soy lecithin and corn oil in the diet. J Anim Sci 1996, 74:1252-1255.
71. Crandell KG, Pagan JD, Harris P, Duren SE A comparison of grain, oil and beet pulp as energy sources for the exercised horse. Equine Vet J 1999, 30:485-489. (suppl).
72. Valentine B, Reynolds A, Wakshlag J, Ducharme N Muscle glycogen, myopathy, and diet. World Equine Vet Rev 1997, 2:27-31.
73. de la Corte F, Valberg SJ, MacLeay JM The effect of feeding a fat supplement to horses with polysaccharide storage myopathy. World Equine Vet Rev 1999, 4:12-19.
74. Valentine BA, van Saun RJ, Thompson KN, Hintz HF Role of dietary carbohydrate and fat in horses with equine polysaccharide storage myopathy. J Am Vet Med Assoc 2001, 219:1537-1544.
75. MacIntyre DL, Reid WD, McKenzie DC Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications. Sports Med 1995, 20:24-40.
76. Proske U, Morgan DL Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 2001, 537:333-345.
77. Sayers SP, Clarkson PM, Rouzier PA, Kamen G Adverse events associated with eccentric exercise protocols: six case studies. Med Sci Sports Exerc 1999, 31:1697-1702.
78. Sayers SP, Clarkson P, Patel JJ Metabolic response to light exercise after exercise-induced rhabdomyolysis. Eur J Appl Physiol 2002, 86:280-282.
79. Foreman JH The exhausted horse syndrome. Vet Clin North Am Equine Pract 1998, 14:205-219.
80. Ji L, Leichtweis S Exercise and oxidative stress: sources of free radicals and their impact on anti-oxidant systems. Age 1997, 20:91-106.
81. Mills PC, Smith NC, Casas I, Harris P, Harris RC, Marlin DJ Effects of exercise intensity and environmental stress on indices of oxidative stress and iron homeostasis during exercise in the horse. Eur J Appl Physiol Occup Physiol 1996, 74:60-66.
82. Chiaradia E, Avellini L, Rueca F, et al. Physical exercise, oxidative stress and muscle damage in racehorses. Comp Biochem Physiol B Biochem Mol Biol 1998, 119:833-836.
83. White A, Estrada M, Walker K, et al. Role of exercise and ascorbate on plasma antioxidant capacity in thoroughbred race horses. Comp Biochem Physiol A Mol Integr Physiol 2001, 128:99-104.
84. Siciliano PD, Parker AL, Lawrence LM Effect of dietary vitamin E supplementation on the integrity of skeletal muscle in exercised horses. J Anim Sci 1997, 75:1553-1560.
85. Brady PS, Ku PK, Ullrey DE Lack of effect of selenium supplementation on the response of the equine erythrocyte glutathione system and plasma enzymes to exercise. J Anim Sci 1978, 47:492-496.
86. Roneus B, Hakkarainen J Vitamin E in serum and skeletal muscle tissue and blood glutathione peroxidase activity from horses with the azoturia-tying-up syndrome. Acta Vet Scand 1985, 26:425-427.
87. Step DL, Divers TJ, Cooper B, Kallfelz FA, Karcher LF, Rebhun WC Severe masseter myonecrosis in a horse. J Am Vet Med Assoc 1991, 198:117-119.
88. Owen RR, Moore JN, Hopkins JB, Arthur D Dystrophic myodegeneration in adult horses. J Am Vet Med Assoc 1977, 171:343-349.
89. Lofstedt J White muscle disease of foals. Vet Clin North Am Equine Pract 1997, 13:169-185.
90. Beech J, Lindborg S, Braund KG Potassium concentrations in muscle, plasma and erythrocytes and urinary fractional excretion in normal horses and those with chronic intermittent exercise-associated rhabdomyolysis. Res Vet Sci 1993, 55:43-51.
91. Shintani S, Shiigai T, Tsukagoshi H Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol 1991, 31:396-398.
92. Bain FT, Merritt AM Decreased erythrocyte potassium concentration associated with exercise-related myopathy in horses. J Am Vet Med Assoc 1990, 196:1259-1261.
93. Johnson PJ, Goetz TE, Foreman JH, Vogel RS, Hoffmann WE, Baker GJ Effect of whole-body potassium depletion on plasma, erythrocyte, and middle gluteal muscle potassium concentration of healthy, adult horses. Am J Vet Res 1991, 52:1676-1683.
94. Muylle E, van den Hende C, Nuytten J, Deprez P, Vlaminck K, Oyaert W Potassium concentration in equine red blood cells: normal values and correlation with potassium levels in plasma. Equine Vet J 1984, 16:447-449.
95. Freestone JF, Gossett K, Carlson GP, Church G Exercise induced alterations in the serum muscle enzymes, erythrocyte potassium and plasma constituents following feed withdrawal or furosemide and sodium bicarbonate administration in the horse. J Vet Intern Med 1991, 5:40-46.
96. Tiidus PM Oestrogen and sex influence on muscle damage and inflammation: evidence from animal models. Curr Opin Clin Nutr Metab Care 2001, 4:509-513.
97. Harris PA The equine rhabdomyolysis syndrome in the United Kingdom: epidemiological and clinical descriptive information. Br Vet J 1991, 147:373-384.
98. Freestone JF, Carlson GR Muscle disorders in the horse: a retrospective study. Equine Vet J 1991, 23:86-90.
99. Beech J, Lindborg S, Fletcher JE, Lizzo F, Tripolitis L, Braund K Caffeine contractures, twitch characteristics and the threshold for Ca(2+)-induced Ca2+ release in skeletal muscle from horses with chronic intermittent rhabdomyolysis. Res Vet Sci 1993, 54:110-117.
100. Lindholm A. Relationship between back problems and muscle disorders: options for prevention and therapy. Conference on Equine Sports Medicine and Science, Waseningen, 1998.
101. Collinder E, Lindholm A, Rasmuson M Genetic markers in standardbred trotters susceptible to the rhabdomyolysis syndrome. Equine Vet J 1997, 29:117-120.
102. McGowan CM, Fordham T, Christley RM Incidence and risk factors for exertional rhabdomyolysis in thoroughbred racehorses in the United Kingdom. Vet Rec 2002, 151:623-626.
103. Frauenfelder HC, Rossdale PD, Ricketts SW, Allen WR Changes in serum muscle enzyme levels associated with training schedules and stage of the oestrous cycle in Thoroughbred racehorses. Equine Vet J 1986, 18:371-374.
104. Beyer IW, Karmali R, Demeester-Mirkine N, Cogan E, Fuss MJ Serum creatine kinase levels in overt and subclinical hypothyroidism. Thyroid 1998, 8:1029-1031.
105. Lochmuller H, Reimers CD, Fischer P, Heuss D, Muller-Hocker J, Pongratz DE Exercise-induced myalgia in hypothyroidism. Clin Invest 1993, 71:999-1001.
106. Foreman JH Metabolic causes of equine exercise intolerance. Vet Clin North Am Equine Pract 1996, 12:537-554.
107. Waldron-Mease E Hypothyroidism and myopathy in racing Thoroughbreds and Standardbreds. J Equine Med Surg 1979, 3:124-128.
108. Harris P, Marlin D, Gray J Equine thyroid function tests: a preliminary investigation. Br Vet J 1992, 148:71-80.
109. Harris PA, Snow DH, Greet TR, Rossdale PD Some factors influencing plasma AST/CK activities in thoroughbred racehorses. Equine Vet J 1990, 9:66-71.
110. Stanley O, Hillidge CJ Alopecia associated with hypothyroidism in a horse. Equine Vet J 1982, 14:165-167.
111. Lowe JE, Baldwin BH, Foote RH, Hillman RB, Kallfelz FA Equine hypothyroidism: the long term effects of thyroidectomy on metabolism and growth in mares and stallions. Cornell Vet 1974, 64:276-295.
112. Harris PA An outbreak of the equine rhabdomyolysis syndrome in a racing yard. Vet Rec 1990, 127:468-470.
113. Lentz LR, Valberg SJ, Balog EM, Mickelson JR, Gallant EM Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 1999, 60:992-999.
114. Mlekoday JA, Mickelson JR, Valberg SJ, Horton JH, Gallant EM, Thompson LV Calcium sensitivity of force production and myofibrillar ATPase activity in muscles from Thoroughbreds with recurrent exertional rhabdomyolysis. Am J Vet Res 2001, 62:1647-1652.
115. MacLeay JM, Valberg SJ, Sorum SA, et al. Heritability of recurrent exertional rhabdomyolysis in Thoroughbred racehorses. Am J Vet Res 1999, 60:250-256.
116. Hildebrand S, Arpin D, Cardinet G Exertional rhabdomyolysis related to malignant hyperthermia using the halothane-caffeine contracture test. Equine exercise physiology 1987, 2:786. ICEEP, Davis, CA. J. Gillespie, N. Robinson (Eds.).
117. Hildebrand SV, Arpin D, Cardinet G Contracture test and histologic and histochemical analyses of muscle biopsy specimens from horses with exertional rhabdomyolysis. J Am Vet Med Assoc 1990, 196:1077-1083.
118. Hodgson DR Exercise-associated myopathy: is calcium the culprit?. Equine Vet J 1993, 25:1-3.
119. Lentz LR, Valberg SJ, Mickelson JR, Gallant EM In vitro contractile responses and contracture testing of skeletal muscle from Quarter Horses with exertional rhabdomyolysis. Am J Vet Res 1999, 60:648-684.
120. Allen GC, Fletcher JE, Huggins FJ, Conti PA, Rosenberg H Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group. Anesthesiology 1990, 72:71-76.
121. Bina S, Karan SM, Lojeski EW, Mongan PD, Muldoon SM Prolonging viability of swine muscle biopsy specimens in malignant hyperthermia testing. Anesth Analg 2001, 93:781-786.
122. Roberts MC, Mickelson JR, Patterson EE, et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 2001, 95:716-725.
123. Kochling A, Wappler F, Winkler G, Schulte am Esch JS Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia. Anaesth Intensive Care 1998, 26:315-318.
124. d'Allaire S, DeRoth L Physiological responses to treadmill exercise and ambient temperature in normal and malignant hyperthermia susceptible pigs. Can J Vet Res 1986, 50:78-83.
125. Waldron-Mease E, Klein LV, Rosenberg H, Leitch M Malignant hyperthermia in a halothane-anesthetized horse. J Am Vet Med Assoc 1981, 179:896-898.
126. Manley SV, Kelly AB, Hodgson D Malignant hyperthermia-like reactions in three anesthetized horses. J Am Vet Med Assoc 1983, 183:85-89.
127. Klein L, Ailes N, Fackelman GE, Kellon E, Rosenberg H Postanesthetic equine myopathy suggestive of malignant hyperthermia. A case report. Vet Surg 1989, 18:479-482.
128. Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991, 253:448-451.
129. Jurkat-Rott K, McCarthy T, Lehmann-Horn F Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 2000, 23:4-17.
130. Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 1988, 263:9310-9315.
131. Ward TL, Valberg SJ, Gallant EM, Mickelson JR Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis. Am J Vet Res 2000, 61:242-247.
132. Tilgen N, Zorzato F, Halliger-Keller B, et al. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet 2001, 10:2879-2887.
133. Monnier N, Procaccio V, Stieglitz P, Lunardi J Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997, 60:1316-1325.
134. Protasi F Structural interaction between RYRs and DHPRs in calcium release units of cardiac and skeletal muscle cells. Front Biosci 2002, 7:d650-d658.
135. Peluso A, Bianchini A Malignant hyperthermia susceptibility in patients with Duchenne's muscular dystrophy. Can J Anaesth 1992, 39:1117-1118.
136. Valentine B, de Lahunta A, Divers TJ, Ducharme N, Orcutt R Clinical and pathologic findings in two draft horses with progressive weakness, and abnormal gait characteristic of shivers syndrome. J Am Vet Med Assoc 1999, 215:1661-1665.
137. Valberg S, Jones J, Smith B, Somerville B Limitations to performance caused by skeletal muscle enzyme deficiencies. Equine Vet J 1995, 18:205-208. (suppl).
138. DiMauro S, Tsujino S, Shanske S, Rowland LP Biochemistry and molecular genetics of human glycogenoses: an overview. Muscle Nerve 1995, 3:S10-S17.
139. Valberg SJ, Macleay JM, Billstrom JA, Hower-Moritz MA, Mickelson JR Skeletal muscle metabolic response to exercise in horses with 'tying-up' due to polysaccharide storage myopathy. Equine Vet J 1999, 31:43-47.
140. Valberg SJ, Townsend D, Mickelson JR Skeletal muscle glycolytic capacity and phosphofructokinase regulation in horses with polysaccharide storage myopathy. Am J Vet Res 1998, 59:782-785.
141. Shulman RG, Bloch G, Rothman DL In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proc Natl Acad Sci USA 1995, 92:8535-8542.
142. Bao Y, Kishnani P, Wu JY, Chen YT Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 1996, 97:941-948.
143. Valberg SJ, Ward TL, Rush B, et al. Glycogen branching enzyme deficiency in quarter horse foals. J Vet Intern Med 2001, 15:572-580.
144. Valberg SJ. Personal communication, 2002.
145. Pickar JG, Spier SJ, Snyder JR, Carlsen RC Altered ionic permeability in skeletal muscle from horses with hyperkalemic periodic paralysis. Am J Physiol 1991, 260:C926-C933.
146. Powell KA, Campbell LC, Tavare JM, Leader DP, Wakefield JA, Gould GW Trafficking of Glut4-green fluorescent protein chimaeras in 3T3-L1 adipocytes suggests distinct internalization mechanisms regulating cell surface glut4 levels. Biochem J 1999, 344(2):535-543.
147. Treadway JL, Hargrove DM, Nardone NA, et al. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem 1994, 269:29956-29961.
148. Hayashi T, Wojtaszewski JF, Goodyear LJ Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 1997, 273:E1039-E1051.
149. Cheatham B GLUT4 and company: SNAREing roles in insulin-regulated glucose uptake. Trends Endocrinol Metab 2000, 11:356-361.
150. Richter EA, Derave W, Wojtaszewski JF Glucose, exercise and insulin: emerging concepts. J Physiol 2001, 535:313-322.
151. Ivy JL, Kuo CH Regulation of GLUT4 protein and glycogen synthase during muscle glycogen synthesis after exercise. Acta Physiol Scand 1998, 162:295-304.
152. Carlström B Uber die atiologie und pathogenese der kreuzlahme des pferdes (Haemaglobinaemia paralytca). Scand Arch 1931, 62:1-69.
153. Valberg S, Haggendal J, Lindholm A Blood chemistry and skeletal muscle metabolic responses to exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J 1993, 25:17-22.
154. Bloom BA, Valentine BA, Gleed RD, Cable CS Postanaesthetic recumbency in a Belgian filly with polysaccharide storage myopathy. Vet Rec 1999, 144:73-75.
155. Guertl B, Noehammer C, Hoefler G Metabolic cardiomyopathies. Int JExp Pathol 2000, 81:349-372.
156. McGowan CM, Posner RE, Christley RM Incidence of exertional rhabdomyolysis in polo horses in the USA and the United Kingdom in the 1999/2000 season. Vet Rec 2002, 150:535-537.
157. Valberg SJ, Geyer C, Sorum SA, Cardinet GH Familial basis of exertional rhabdomyolysis in quarter horse-related breeds. Am J Vet Res 1996, 57:286-290.
158. Meyer TS, Fedde MR, Cox JH, Erickson HH Hyperkalaemic periodic paralysis in horses: a review. Equine Vet J 1999, 31:362-367.
159. Reynolds J, Potter G, Greene L, et al. Genetic-diet interactions in the hyperkalemic periodic paralysis syndrome in Quarter Horses fed varying amounts of potassium. J Equine Vet Sci 1998, 18:591-600.
160. Cox J An episodic weakness in four horses associated with intermittent serum hyperkalemia and the similarity of the disease to hyperkalemic periodic paralysis in man. Proceedings of the 31st Annual Meeting of the American Association of Equine Practitioners, 1985 vol. 21: 383-391.
161. Cox J, DeBowes R Episodic weakness caused by hyperkalemic periodic paralysis in horses. Comp Cont Educ Pract Vet 1990, 12:83-88.
162. Spier SJ, Carlson GP, Holliday TA, Cardinet GH, Pickar JG Hyperkalemic periodic paralysis in horses. J Am Vet Med Assoc 1990, 197:1009-1017.
163. Naylor JM Hyperkalemic periodic paralysis. Vet Clin North Am Equine Pract 1997, 13:129-144.
164. Guglick MA, MacAllister CG, Breazile JE Laryngospasm, dysphagia, and emaciation associated with hyperkalemic periodic paralysis in a horse. J Am Vet Med Assoc 1996, 209:115-117.
165. Carr EA, Spier SJ, Kortz GD, Hoffman EP Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. J Am Vet Med Assoc 1996, 209:798-803.
166. Beech J, Fletcher JE, Tripolitis L, Lindborgh S Effects of phenytoin in two myotonic horses with hyperkalemic periodic paralysis. Muscle Nerve 1992, 15:932-936.
167. Glazier DB, Littledike ET, Evans RD Electrocardiographic changes in induced hyperkalemia in ponies. Am J Vet Res 1982, 43:1934-1937.
168. Cornick JL, Seahorn TL, Hartsfield SM Hyperthermia during isoflurane anaesthesia in a horse with suspected hyperkalaemic periodic paralysis. Equine Vet J 1994, 26:511-514.
169. Robertson SA, Green SL, Carter SW, Bolon BN, Brown MP, Shields RP Postanesthetic recumbency associated with hyperkalemic periodic paralysis in a quarter horse. J Am Vet Med Assoc 1992, 201:1209-1212.
170. Castex AM, Bertone JJ ECG of the month. Sinus tachycardia and hyperkalemia in a horse. J Am Vet Med Assoc 1989, 194:654-655.
171. Church S Hyperkalaemic periodic paralysis in Australian quarter horses. Aust Vet J 1995, 72:314-316.
172. Beech J, Lindborg S Prophylactic efficacy of phenytoin, acetazolamide and hydrochlorothiazide in horses with hyperkalaemic periodic paralysis. Res Vet Sci 1995, 59:95-101.
173. Bailey JE, Pablo L, Hubbell JA Hyperkalemic periodic paralysis episode during halothane anesthesia in a horse. J Am Vet Med Assoc 1996, 208:1859-1865.
174. Naylor JM, Robinson JA, Crichlow EC, Steiss JE Inheritance of myotonic discharges in American quarter horses and the relationship to hyperkalemic periodic paralysis. Can J Vet Res 1992, 56:62-66.
175. Stewart RH, Bertone JJ, Yvorchuk-St Jean K, Reed SM, Neil WH Possible normokalemic variant of hyperkalemic periodic paralysis in two horses. J Am Vet Med Assoc 1993, 203:421-424.
176. Naylor JM Equine hyperkalemic periodic paralysis: review and implications. Can Vet J 1994, 35:279-285.
177. Spier SJ, Carlson GP, Harrold D, Bowling A, Byrns G, Bernoco D Genetic study of hyperkalemic periodic paralysis in horses. J Am Vet Med Assoc 1993, 202:933-937.
178. Traub-Dargatz JL, Ingram JT, Stashak TS, et al. Respiratory stridor associated with polymyopathy suspected to be hyperkalemic periodic paralysis in four quarter horse foals. J Am Vet Med Assoc 1992, 201:85-89.
179. Reed SM, Hegreberg GA, Bayly WM, Brown CM, Paradis MR, Clemmons RM Progressive myotonia in foals resembling human dystrophia myotonica. Muscle Nerve 1988, 11:291-296.
180. Montagna P, Liguori R, Monari L, et al. Equine muscular dystrophy with myotonia. Clin Neurophysiol 2001, 112:294-299.
181. Steinberg S, Botelho S Myotonia in a horse. Science 1962, 137:979-980.
182. Naylor JM, Jones V, Berry SL Clinical syndrome and diagnosis of hyperkalaemic periodic paralysis in quarter horses. Equine Vet J 1993, 25:227-232.
183. Robinson JA, Naylor JM, Crichlow EC Use of electromyography for the diagnosis of equine hyperkalemic periodic paresis. Can J Vet Res 1990, 54:495-500.
184. Naylor JM Selection of quarter horses affected with hyperkalemic periodic paralysis by show judges. J Am Vet Med Assoc 1994, 204:926-928.
185. Bowling AT, Byrns G, Spier S Evidence for a single pedigree source of the hyperkalemic periodic paralysis susceptibility gene in quarter horses. Anim Genet 1996, 27:279-281.
186. Rose B, Post T, Narins R Clinical physiology of acid-base and electrolyte disorders 2000, McGraw-Hill, New York.
187. Bendheim PE, Reale EO, Berg BO beta-Adrenergic treatment of hyperkalemic periodic paralysis. Neurology 1985, 35:746-749.
188. Fletcher JE, Erwin K, Beech J Phenytoin increases specific triacylglycerol fatty esters in skeletal muscle from horses with hyperkalemic periodic paralysis. Biochim Biophys Acta 1993, 1168:292-298.
189. Yudkowsky ML, Beech J, Fletcher JE Phenytoin alters transcript levels of hormone-sensitive lipase in muscle from horses with hyperkalemic periodic paralysis. Arch Biochem Biophys 1998, 358:264-270.
190. Duren S Feeding management of horses with hyperkalemic periodic paralysis. World Equine Vet Res 1998, 3:5-8.
191. Cox J, DeBowes RM, Bayer J. Response of normal and acetazolamide treated horses to oral potassium chloride challenge. Proceedings of the 6th Annual Veterinary Medical Forum, 1988.
192. Hoskins B Studies on the mechanism of action of acetazolamide in the prophylaxis of hyperkalemic periodic paralysis. Life Sci 1977, 20:343-349.
193. Alberts MK, Clarke CR, MacAllister CG, Homer LM Pharmacokinetics of acetazolimide after intravenous and oral administration in horses. Am J Vet Res 2000, 61:965-968.
194. Smith CA Hyperkalemic periodic paralysis presents medical and ethical challenge. J Am Vet Med Assoc 1993, 202:1203-1209.
195. Steiss J, Naylor JR Episodic muscle tremors in a quarter horse: Resemblance to hyperkalemic periodic paralysis. Can Vet J 1986, 27:332.
196. Cannon SC Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci 1996, 19:3-10.
197. Hoffman EP Voltage-gated ion channelopathies: inherited disorders caused by abnormal sodium, chloride, and calcium regulation in skeletal muscle. Annu Rev Med 1995, 46:431-441.
198. Rudolph JA, Spier SJ, Byrns G, Hoffman EP Linkage of hyperkalaemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene. Anim Genet 1992, 23:241-250.
199. Rudolph JA, Spier SJ, Byrns G, Rojas CV, Bernoco D, Hoffman EP Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding. Nat Genet 1992, 2:144-147.
200. Naylor JM, Robinson JA, Bertone J Familial incidence of hyperkalemic periodic paralysis in quarter horses. J Am Vet Med Assoc 1992, 200:340-343.
201. Zhou J, Spier SJ, Beech J, Hoffman EP Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis. Hum Mol Genet 1994, 3:1599-1603.
202. Hanna WJ, Tsushima RG, Sah R, McCutcheon LJ, Marban E, Backx PH The equine periodic paralysis Na+ channel mutation alters molecular transitions between the open and inactivated states. J Physiol 1996, 497(2):349-364.
203. Cannon SC, Hayward LJ, Beech J, Brown RH Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis. J Neurophysiol 1995, 73:1892-1899.
204. Lehmann-Horn F, Iaizzo PA, Hatt H, Franke C Altered gating and conductance of Na+ channels in hyperkalemic periodic paralysis. Pflugers Arch 1991, 418:297-299.
205. Cannon SC, Brown RH, Corey DP A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation. Neuron 1991, 6:619-626.
206. Ricker K, Camacho LM, Grafe P, Lehmann-Horn F, Rudel R Adynamia episodica hereditaria: what causes the weakness?. Muscle Nerve 1989, 12:883-891.
207. Steele D, Naylor JM Hyperkalemic periodic paralysis, plasma lactate and exercise tolerance. J Equine Vet Sci 1996, 202:933-937.
208. Maxson-Sage A, Parente EJ, Beech J, Lindborg S, May LL, Teleis DC Effect of high-intensity exercise on arterial blood gas tensions and upper airway and cardiac function in clinically normal quarter horses and horses heterozygous and homozygous for hyperkalemic periodic paralysis. Am J Vet Res 1998, 59:615-618.
209. McKerrell RE Myotonia in man and animals: confusing comparisons. Equine Vet J 1987, 19:266-267.
210. Jamison JM, Baird JD, Smith-Maxie LL, Hulland TJ A congenital form of myotonia with dystrophic changes in a quarterhorse. Equine Vet J 1987, 19:353-358.
211. Hegreberg GA, Reed SM Skeletal muscle changes associated with equine myotonic dystrophy. Acta Neuropathol 1990, 80:426-431.
212. Lindholm A Diagnosis of muscular problems. Laboratory diagnosis for sports horses 1998, 55-61. Wageningen Pers, Wageningen. A. Lindner (Ed.).
213. Andrews FM, Spurgeon TL, Reed SM Histochemical changes in skeletal muscles of four male horses with neuromuscular disease. Am J Vet Res 1986, 47:2078-2083.
214. Roneus B, Lindholm A, Jonsson L Myotoni hos hast. Svensk Veterinartidning 1983, 35:217-220.
215. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
216. Larkin K, Fardaei M Myotonic dystrophy - a multigene disorder. Brain Res Bull 2001, 56:389-395.
217. Meola G Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve 2000, 23:1789-1799.
218. Johansson A, Carlstrom K, Ahren B, et al. Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy. J Clin Endocrinol Metab 2000, 85:3169-3176.
219. Mastrogiacomo I, Pagani E, Novelli G, et al. Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation. J Endocrinol Invest 1994, 17:381-383.
220. DiMauro S, Bonilla E, Davidson M, Hirano M, Schon EA Mitochondria in neuromuscular disorders. Biochim Biophys Acta 1998, 1366:199-210.
221. Valberg SJ, Carlson GP, Cardinet GH, et al. Skeletal muscle mitochondrial myopathy as a cause of exercise intolerance in a horse. Muscle Nerve 1994, 17:305-312.
222. Larsson NG, Oldfors A Mitochondrial myopathies. Acta Physiol Scand 2001, 171:385-393.
223. Xu X, Arnason U The complete mitochondrial DNA sequence of the horse, Equus caballus: extensive heteroplasmy of the control region. Gene 1994, 148:357-362.
224. Turner AS, Trotter GW Fibrotic myopathy in the horse. J Am Vet Med Assoc 1984, 184:335-338.
225. Bishop R Fibrotic myopathy in the gracilis muscle of a horse. Vet Med Small Anim Clin 1972, 67:270.
226. Irwin DH, Howell DW Fibrotic myopathy, haematomas and scar tissue in the gaskin area of the thoroughbred. J S Afr Vet Assoc 1981, 52:65-66.
227. Reef VB Equine diagnostic ultrasound 1998, 145-147. Saunders, Philadelphia.
228. Valentine BA, Rousselle SD, Sams AE, Edwards RB Denervation atrophy in three horses with fibrotic myopathy. J Am Vet Med Assoc 1994, 205:332-336.
229. Gomez-Villamandos R, Santisteban J, Ruiz I, Avila I Tenotomy of the tibial insertion of the semitendinosus muscle of two horses with fibrotic myopathy. Vet Rec 1995, 136:67-68.
230. McIlwraith W, Robertson J McIlwraith & Turner's equine surgery: advanced techniques 1998, 213-215. Williams and Wilkins, Baltimore, MD.
231. Beauchamp JR, Heslop L, Yu DS, et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000, 151:1221-1234.